Based on evidence that HDAC inhibition activates p16 [39–41], we confirmed HDAC3 interactions on p16 to be higher in colon tumors of WT vs. Nrf2−/+ mice (Fig. 6f), and inversely associated with p16 mRNA levels (Fig. 6a). Here, HDAC3 is linked to colonic neoplasm.